Calcium phosphate granules in treatment of peri-implantitis

Not Applicable

Completed

• Conditions: Bone loss around dental implants - peri-implantitis; Oral Health

• Registration Number: ISRCTN13514478
• Lead Sponsor: Riga Stradinš University

Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30631412 (added 06/11/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-05-30
• Study Start: 2018-10-24
• Last Update Posted: 6 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Peri-implantitis at any stage
2. Use of biphasic calcium phosphate (HAP/ßTCP) granules produced in Riga Technical University Rudolfs Cimdins Riga Biomaterials Innovation and Development Centre
3. Presence of a 3D CT before the treatment
4. Aged 40-71 years

Exclusion Criteria

N/A

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Alveolar bone density, assessed using 3D CT scans before the operation and 5 years after the operation

Secondary Outcome Measures

Name	Time	Method
Percentage of bone tissue loss, assessed using 3D CT scans before the operation and 5 years after the operation